Cryopreserved ampule of Human Umbilical Vein Endothelial Cells (HUVEC), from pooled donors, in EGMTM-2 and containing ≥ 500,000 cells
Cryopreserved ampule of Human Human Umbilical Vein Endothelial Cells (HUVEC) from a single donor containing ≥ 500,000 cells
Cryopreserved ampule of Human Umbilical Vein Endothelial Cells (HUVEC) from pooled donors, containing ≥ 500,000 cells
Cryopreserved ampule of Human Umbilical Vein Endothelial Cells (HUVEC) from pooled donors, cultured in EGMTM-2, pre-screened for Angiogenesis and containing ≥ 500,000 cells
Cryopreserved ampule of Adult Human Dermal Microvascular Endothelial Cells (HMVEC-d Ad) containing ≥ 500,000 cells
Cryopreserved ampule of Human Umbilical Vein Endothelial Cells (HUVEC) without VEGF, from a single donor, cultured in EGMTM Plus and containing ≥ 500,000 cells
-
Terms and ConditionsCD34+ cells BOGO
-
Instructions and Technical Sheet- Human CD34+ Cells
-
Primary Blood and Immune Cells for ResearchPresentation (PDF) showcasing Lonza's portfolio and capabilities of primary blood and immune cells for research.
-
Primary Cells and Media Reference GuideA comprehensive collection of Lonza primary cell and media products supporting many research areas.
-
Hematopoietic and Immune Cell Products - Essential Tools for Hematopoietic ResearchLonza_Brochures_Hematopoietic_and_Immune_Cell_Products_-_Essential_Tools_for_Hematopoietic_Research.pdf
-
Primary Normal Human Cells and MediaIn Vivo Relevance. In Vitro Results. Updated and revised cell content.
-
References - X-Vivo™Overview of relevant references
-
Mitosis of CD34+ cells with Nanolive's 3D Cell Explorer
-
CD34+ Cells for Cell and Gene Therapy Process DevelopmentIn this interview Dr. Manon Destalminil, Bioprocessing Project Leader at CellProthera, discusses the advantages of using research-grade CD34+ cells for cell and gene therapy process development. Please register to read.
-
Human CD34+ Cells Technical information and instructions for use